Tsuchiya, T., Sadahiro, S., Sasaki, K., Kondo, K., Katsumata, K., Nishimura, G., . . . Saji, S. (2014). Safety analysis of two different regimens of uracil–tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial. Springer Berlin Heidelberg.
Chicago Style citaatTsuchiya, Takashi, et al. Safety Analysis of Two Different Regimens of Uracil–tegafur Plus Leucovorin As Adjuvant Chemotherapy for High-risk Stage II and III Colon Cancer in a Phase III Trial Comparing 6 With 18 months of Treatment: JFMC33-0502 Trial. Springer Berlin Heidelberg, 2014.
MLA citatieTsuchiya, Takashi, et al. Safety Analysis of Two Different Regimens of Uracil–tegafur Plus Leucovorin As Adjuvant Chemotherapy for High-risk Stage II and III Colon Cancer in a Phase III Trial Comparing 6 With 18 months of Treatment: JFMC33-0502 Trial. Springer Berlin Heidelberg, 2014.